MAI Capital Management 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-19 11:30 am Purchase | 2022-07-12 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | MAI Capital Management | 2,675,376 5.800% | 2,675,376 (New Position) | Filing |